APA (7th ed.) Citation

Amatangelo, M., Flynt, E., Stong, N., Ortiz, M., Ray, P., Wang, M., . . . Gandhi, A. K. (2023). RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects. Blood, 142(Supplement 1), 4665. https://doi.org/10.1182/blood-2023-178912

Chicago Style (17th ed.) Citation

Amatangelo, Michael, et al. "RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects." Blood 142, no. Supplement 1 (2023): 4665. https://doi.org/10.1182/blood-2023-178912.

MLA (9th ed.) Citation

Amatangelo, Michael, et al. "RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects." Blood, vol. 142, no. Supplement 1, 2023, p. 4665, https://doi.org/10.1182/blood-2023-178912.